scispace - formally typeset
Journal ArticleDOI

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis

Reads0
Chats0
TLDR
The revised criteria facilitate the diagnosis of MS in patients with a variety of presentations, including “monosymptomatic” disease suggestive of MS, disease with a typical relapsing‐remitting course, and disease with insidious progression, without clear attacks and remissions.
Citations
More filters
Journal ArticleDOI

Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells.

TL;DR: The increase in T(Reg)-cell inhibitory capacity mediated by interferon beta treatment can be explained by its effect on the homeostatic balance within the T(reg) cell compartment.
Journal ArticleDOI

Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS

TL;DR: Findings suggest persons being treated with IFN-β should have vitamin D status monitored and maintained in the sufficiency range, suggesting part of the therapeutic effects of IFn-β on relapse in MS may be through modulation of vitamin D metabolism.
Journal ArticleDOI

Voxel-based analysis of MTR images: a method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis.

TL;DR: To determine whether voxel‐based analysis of magnetization transfer ratio (MTR) maps can provide evidence of a coherent pattern of gray matter (GM) macroscopic and microscopic tissue damage in patients at the earliest stage of multiple sclerosis (MS),
Journal ArticleDOI

Interferon beta for secondary progressive multiple sclerosis

TL;DR: Results show that IFNs' anti-inflammatory effect is unable to retard progression, when established, and no new RCTs for IFNs versus placebo in SPMS will probably be undertaken, because research is now focusing on innovative drugs.
References
More filters
Journal ArticleDOI

The clinical course of neuromyelitis optica (Devic's syndrome)

TL;DR: Clinical, laboratory, and imaging features generally distinguish neuromyelitis optica from MS, and patients with relapsing optic neuritis and myelitis may have neuromyeliitis opticas rather than MS.
Journal ArticleDOI

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.

TL;DR: It is concluded that a four-parameter dichotomized MRI model including gadolinium-enhancement, juxtacortical, infratentorial and periventricular lesions best predicts conversion to clinically definite multiple sclerosis.
Journal ArticleDOI

MRI in the diagnosis of MS A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT

TL;DR: MRI was the best method for demonstrating dissemination in space and laboratory-supported definite MS (LSDMS) could be diagnosed in 85 patients of the total 200, and MRI predicted that diagnosis in 18/19 (95%).
Related Papers (5)